News

RNA has newly identified role: Repairing serious DNA damage to maintain the genome
Researchers discovered a previously unknown function of RNA, potentially opening the door to new ways to treat cancer and ...
MedCity News3d
BioNTech to Buy CureVac in $1.25B Stock Deal That Would Also End mRNA Patent Dispute
BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...
Shining a Light on the World of Tiny Proteins
For a long time, scientists depended on luck to find new proteins. In 1840, for example, Friedrich Ludwig Hünefeld, a German ...
STAT3d
FDA clears Moderna’s RSV vaccine for use in people aged 18 to 59
The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a ...
Kennedy Remakes CDC Committee in His Own Vaccine-Skeptical Image
The health secretary fired all the members of the Advisory Committee on Immunization Practices late on Monday.
Metro Weekly2d
HIV Cure Could Emerge From COVID-19 mRNA Breakthrough
Researchers in Australia use COVID-era mRNA technology to expose hidden HIV in white blood cells, offering hope for a future ...
US FDA approves expanded use of Moderna's RSV vaccine for at-risk adults
The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus vaccine to a ...
Why Trump turned against ‘gold standard’ mRNA vaccines
President Trump’s administration has slammed the brakes on development of messenger RNA (mRNA) vaccines, which proved their lifesaving potential during the COVID-19 pandemic but have come ...
BioNTech's Acquisition Of CureVac Brings Complementary Method To Target Cancer
The BioNTech SE acquisition of CureVac N.V. brings together complementary technologies, as both are developing mRNA ...